Provided by Tiger Trade Technology Pte. Ltd.

Goldman Sachs Future Health Care Equity ETF

37.35
-0.0885-0.24%
Post-market: 37.440.0885+0.24%16:10 EDT
Volume:57
Turnover:2K
Market Cap:19.61M
PE:- -
High:37.35
Open:37.44
Low:37.35
Close:37.44
52wk High:38.66
52wk Low:31.32
Shares:525.00K
Float Shares:525.00K
Volume Ratio:0.09
T/O Rate:0.01%
Dividend:0.11
Dividend Rate:0.30%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Zepbound Linked to Lower Healthcare Costs in Adults over Age 55 with Obesity According to a Real-World Study

THOMSON REUTERS
·
Aug 26

Analysts Are Bullish on These Healthcare Stocks: Zymeworks (ZYME), Johnson & Johnson (JNJ)

TIPRANKS
·
Aug 26

UnitedHealth Optum CEO Patrick Hugh Conway Disposes of 1,169 Shares for $455,910

Reuters
·
Aug 26

Sweden's BioArctic Q2 Revenue Falls Despite Higher Leqembi Royalties

Reuters
·
Aug 26

AlzeCure Swings to Q2 FY26 Profit of SEK 80.18 Million; Net Sales Rise to SEK 97.33 Million

Reuters
·
Aug 26

SR Medical Jumps Over 5% in Morning Trade, Pivoting to AI-Driven Digital Healthcare

Deep News
·
Aug 26

Unified Pathology Index Launches Nationwide, One Code Bridges Data Gaps for Precision Care

Stock News
·
Aug 26

Johnson & Johnson (JNJ) Wins FDA Approval For First Warm Autoimmune Hemolytic Anemia Treatment

Simply Wall St.
·
Aug 26

Eli Lilly (LLY) Stock Trades Below Fair Value On Cash Flow

Simply Wall St.
·
Aug 26

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 26

Merck & Co. Inc. Stock Rises 3.8%, Outperforms Peers

Dow Jones
·
Aug 26

Eli Lilly & Co. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Aug 26

Dow up 136 Points on Gains for Shares of Merck, Goldman Sachs

Dow Jones
·
Aug 26

Eli Lilly Stock (LLY) Rattled as Companies Decline to Cover Weight-Loss Drug Costs

TIPRANKS
·
Aug 26

Merck & Co Inc Stock (MRK) Moved Up by 3.76% on Aug 25: A Full Analysis

TradingKey
·
Aug 26

More US Employers to Drop Weight-Loss Drugs in 2027, as Healthcare Costs Increase

Reuters
·
Aug 26

Lilly’s LY4395089 Interaction Study Marks Quiet but Important Early-Stage Progress

TIPRANKS
·
Aug 26

Moderna Stock (MRNA) Rises 12.5% Today Following Phase 3 mRNA Cancer Vaccine Win with Merck

TIPRANKS
·
Aug 26

BeOne announces FDA approval for Tevimbra-based reginmen for HER2+ GEA

TIPRANKS
·
Aug 25

U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma

GlobeNewswire
·
Aug 25